Depression News

Researchers successfully developed and implemented a workflow for screening caregivers of children with asthma for depression and referring them for mental health care, according to a study published in Journal of Asthma.

Adults older than 60 years have significantly worse cognition and higher depression after experiencing moderate to severe trauma, according to research presented at the Alzheimer’s Association International Conference.

The American Psychiatric Association has announced that CEO and Medical Director Saul Levin, MD, MPA, will step down from his role with the organization, which he has held since July 2013, effective May 31, 2024.

An advisory panel composed of 21 psychiatrists and other mental health clinicians has developed a set of educational materials to address maternal mental health needs.

A meta-analysis performed by an international group of researchers revealed no association between depression or anxiety and increased overall cancer risk.

The FDA approved zuranolone as the first oral treatment for postpartum depression in adults, according to an agency press release.

The investigational neuroactive steroid zuranolone was generally well-tolerated and demonstrated significant improvement in symptoms in women with postpartum depression, according to a study published in The American Journal of Psychiatry.

A clinical-stage biopharmaceutical company and a global contract research organization have partnered to support the ongoing development of investigational, psychedelic therapeutics to treat a range of psychiatric disorders.

monotherapy for the treatment of major depressive disorder, is set to enter a phase 3 clinical program, with a new drug application expected in 2025, according to a press release.

Post-acne scarring should be treated as a distinct condition from acne vulgaris and deserves a comprehensive and unique clinical approach, according to a study.